Free Trial

Interpace Biosciences (IDXG) News Today

Interpace Biosciences logo
$2.01 +0.01 (+0.40%)
As of 03:50 PM Eastern

IDXG Latest News

PDI: 15% Yield That Never Keeps Me Up At Night
PDI: Consistent Payouts Will Erode The NAV Further
PDI & Robex Merger Proceeding to Implementation
Interpace Biosciences posts Q4 results, shares flat
Can CMPDIL IPO deliver long-term gains for high risk investors?
Consider PDI If You Really Want An Income CEF
Coal India arm CMPDI to launch IPO on March 20. All you need to know
Stop Overpaying For PDI
PDI: A Special Entry Point For This Fund
PDI: A 15% Yielding Flagship Ready For The Rate-Cut Cycle
Robex Shareholders Approve PDI Merger
PDI: An Out-Performance Candidate For 2026
PDI: You Were Clearly Warned (Rating Upgrade)
Proposal to Acquire PDI No Longer Deemed Superior
PDI: This 15% Yield Is Finally A Buy
PDI: 15% Yield Is Near 10-Year Peak (Rating Upgrade)
Interpace Biosciences Reports Q3 2025 Earnings
PDI: I Tried To Plot A Bear Case, I Failed
Get Interpace Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for IDXG and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IDXG Media Mentions By Week

IDXG Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

IDXG
News Sentiment

0.60

0.60

Average
Medical
News Sentiment

IDXG News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

IDXG Articles
This Week

4

1

IDXG Articles
Average Week

Get the Latest News and Ratings for IDXG and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Interpace Biosciences and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (OTCMKTS:IDXG) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners